IL143123A0 - Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof - Google Patents
Methods for the preparation of nucleic acid and polypeptide libraries and uses thereofInfo
- Publication number
- IL143123A0 IL143123A0 IL14312399A IL14312399A IL143123A0 IL 143123 A0 IL143123 A0 IL 143123A0 IL 14312399 A IL14312399 A IL 14312399A IL 14312399 A IL14312399 A IL 14312399A IL 143123 A0 IL143123 A0 IL 143123A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acid
- recombination
- methods
- libraries
- replication
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ceramic Products (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002509A IT1303776B1 (it) | 1998-11-19 | 1998-11-19 | Processo per la preparazione di genoteche, di polipeptidi utilizzandodette genoteche e i polipepti ottenuti. |
| PCT/EP1999/008856 WO2000031246A2 (en) | 1998-11-19 | 1999-11-18 | Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL143123A0 true IL143123A0 (en) | 2002-04-21 |
Family
ID=11381090
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14312399A IL143123A0 (en) | 1998-11-19 | 1999-11-18 | Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof |
| IL143123A IL143123A (en) | 1998-11-19 | 2001-05-14 | Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL143123A IL143123A (en) | 1998-11-19 | 2001-05-14 | Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1131421B1 (de) |
| AT (1) | ATE333502T1 (de) |
| AU (1) | AU3790300A (de) |
| CA (1) | CA2350779A1 (de) |
| DE (1) | DE69932446T2 (de) |
| ES (1) | ES2268907T3 (de) |
| IL (2) | IL143123A0 (de) |
| IT (1) | IT1303776B1 (de) |
| WO (1) | WO2000031246A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6780620B1 (en) | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
| US6686154B2 (en) * | 2000-06-05 | 2004-02-03 | Zyomyx, Inc. | Screening of phage displayed peptides without clearing of the cell culture |
| EP1457559B1 (de) * | 2001-11-22 | 2008-01-16 | Keio University | Künstliche antikörperbibliothek mit super-repertoire |
| CN105153307A (zh) | 2010-05-04 | 2015-12-16 | 梅里麦克制药股份有限公司 | 抗表皮生长因子受体(egfr)的抗体及其用途 |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| WO2013173582A1 (en) | 2012-05-17 | 2013-11-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hepatitis c virus neutralizing antibody |
| US9751931B2 (en) | 2012-10-26 | 2017-09-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hepatitis C virus neutralizing antibodies and methods |
| WO2018129451A2 (en) | 2017-01-09 | 2018-07-12 | Merrimack Pharmaceuticals, Inc. | Anti-fgfr antibodies and methods of use |
| TWI788340B (zh) | 2017-04-07 | 2023-01-01 | 美商必治妥美雅史谷比公司 | 抗icos促效劑抗體及其用途 |
| EP3694552A1 (de) | 2017-10-10 | 2020-08-19 | Tilos Therapeutics, Inc. | Anti-lap-antikörper und verwendungen davon |
| CN113056487A (zh) | 2018-09-18 | 2021-06-29 | 梅里麦克制药股份有限公司 | 抗tnfr2抗体及其用途 |
| EP3863722A2 (de) | 2018-10-10 | 2021-08-18 | Tilos Theapeutics, Inc. | Anti-lap-antikörper und verwendungen davon |
| EP3870604B1 (de) * | 2018-10-26 | 2022-11-23 | F. Hoffmann-La Roche AG | Screeningverfahren für multispezifische antiköper mittels rekombinase-vermitteltem kassettenaustausch |
| CN113874083A (zh) | 2019-03-01 | 2021-12-31 | 梅里麦克制药股份有限公司 | 抗-tnfr2抗体及其用途 |
| CN113661173B (zh) | 2019-03-29 | 2024-10-01 | 豪夫迈·罗氏有限公司 | 通过以限定的组织形式靶向整合多个表达盒来产生表达FcRn的细胞的方法 |
| WO2021190631A1 (zh) * | 2020-03-27 | 2021-09-30 | 泷搌(上海)生物科技有限公司 | 在哺乳动物细胞表面展示双特异性抗体的方法及载体 |
| EP4132971A1 (de) | 2020-04-09 | 2023-02-15 | Merck Sharp & Dohme LLC | Affinitätsgereifte anti-lap-antikörper und verwendungen davon |
| CN117430696A (zh) * | 2022-07-22 | 2024-01-23 | 北京智仁美博生物科技有限公司 | 用于表达Fab片段库的重组系统 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5728557A (en) * | 1995-06-01 | 1998-03-17 | Merck & Co., Inc. | Method of making herpes simplex type 1 mutants and mutants so produced |
| WO1998028416A1 (en) * | 1996-12-20 | 1998-07-02 | Novo Nordisk A/S | In vivo recombination |
-
1998
- 1998-11-19 IT IT1998MI002509A patent/IT1303776B1/it active
-
1999
- 1999-11-18 AT AT99972677T patent/ATE333502T1/de not_active IP Right Cessation
- 1999-11-18 DE DE69932446T patent/DE69932446T2/de not_active Expired - Lifetime
- 1999-11-18 CA CA002350779A patent/CA2350779A1/en not_active Abandoned
- 1999-11-18 WO PCT/EP1999/008856 patent/WO2000031246A2/en not_active Ceased
- 1999-11-18 EP EP99972677A patent/EP1131421B1/de not_active Expired - Lifetime
- 1999-11-18 ES ES99972677T patent/ES2268907T3/es not_active Expired - Lifetime
- 1999-11-18 IL IL14312399A patent/IL143123A0/xx unknown
- 1999-11-18 AU AU37903/00A patent/AU3790300A/en not_active Abandoned
-
2001
- 2001-05-14 IL IL143123A patent/IL143123A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69932446D1 (de) | 2006-08-31 |
| ATE333502T1 (de) | 2006-08-15 |
| EP1131421A2 (de) | 2001-09-12 |
| IT1303776B1 (it) | 2001-02-23 |
| ES2268907T3 (es) | 2007-03-16 |
| EP1131421B1 (de) | 2006-07-19 |
| DE69932446T2 (de) | 2007-01-04 |
| WO2000031246A2 (en) | 2000-06-02 |
| AU3790300A (en) | 2000-06-13 |
| WO2000031246A3 (en) | 2000-08-17 |
| ITMI982509A1 (it) | 2000-05-19 |
| CA2350779A1 (en) | 2000-06-02 |
| IL143123A (en) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL143123A0 (en) | Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof | |
| AU699568B2 (en) | A method for identification of biologically active peptides and nucleic acids | |
| ATE391789T1 (de) | Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen | |
| DE69738905D1 (de) | Methoden und zusammensetzungen zur transformation von zellen | |
| WO2002000875A3 (en) | Compositions and methods for generating expression vectors through site-specific recombination | |
| AU681705B2 (en) | Endosomolytically active particles | |
| AU2715302A (en) | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites | |
| EP1227147A3 (de) | Rekombinatorische Klonierung unter Verwendung genmanipulierter Rekombinationsorte | |
| NZ337676A (en) | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same | |
| EP1229047A3 (de) | IL-1 Rezeptor Fusionsproteine verwendet als Antagoniste und Verfahren zu deren Verwendung und Herstellung | |
| DK0749444T3 (da) | Human/dyre-faktor VIII-hybrid | |
| CO5590973A2 (es) | Acido nucleico de adenovirus de simio y secuiencias de aminoacidos, vectores que contienen los mismos y metodos de uso | |
| DE69941701D1 (de) | Mutanten von flt3-l und ihre verwendungen | |
| DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| Canu et al. | Incorporation of Non‐canonical Amino Acids into 2, 5‐Diketopiperazines by Cyclodipeptide Synthases | |
| ID27206A (id) | Generasi produk-produk perbanyakan gena dari protein-protein fusi simerik melalui pemutusan endoprotease ubikuitus | |
| MX2023014557A (es) | Sistemas crispr-transposon para modificacion de adn. | |
| CA2257115A1 (en) | Spruce budworm antifreeze proteins, genes and methods of using same | |
| Mathews et al. | Mass spectrometrically derived amino acid sequence of thioredoxin from Chlorobium, an evolutionarily prominent photosynthetic bacterium. | |
| EP1169641A4 (de) | Proteomabbau | |
| WO1999009417A3 (en) | Method of drug selection | |
| WO1999067375A3 (en) | Screening system | |
| US20030082514A1 (en) | Method for identification of biologically active peptides and nucleic acids | |
| Amato | A high-flying fix for ozone loss |